Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioStorage Technologies Adding New Service in Germany

Published: Wednesday, October 17, 2012
Last Updated: Wednesday, November 07, 2012
Bookmark and Share
BioStorage Technologies announces the expansion of its temperature-controlled storage options to include vapor-phase liquid nitrogen preservation at its state-of-the-art biorepository facility in Griesheim, Germany.

The expansion of vapor phase liquid nitrogen storage allows BioStorage Technologies to offer the widest range of storage options available in the industry. The company's temperature-controlled storage options include: bulk sample storage at 15 degrees Celsius to 27 degrees Celsius, cold sample storage at -20 degrees Celsius and 5 degrees Celsius, and ultra-low temperature storage at -70 degrees Celsius and -80 degrees Celsius, and liquid nitrogen storage -190 degrees Celsius. To ensure biomaterial assets are stored at the precise temperature, samples are continuously monitored and tracked by BioStorage's proprietary ISISS® technology, thereby providing a regulatory audit trail of location and movement of each sample within our facility.

"To meet the needs of our expanding client base and the growing need for biopreservation of cellular-based samples, we expanded vapor-phase liquid nitrogen storage capability in our Germany based operations, which provides our European clients with the full range of storage conditions they require for specimen preservation, ranging from -190 degrees Celsius to controlled room temperature storage," said Russ Hager, Senior Director of Global Biorepository Operations, BioStorage Technologies. "Integrating this expanded liquid nitrogen storage capability into our current processes gives our customers greater flexibility in meeting their long-term storage needs without sacrificing the level of quality and sample management they require."

BioStorage Technologies manages the complete life cycle of a sample from planning, collection, transportation, protection and retrieval to sample disposal. The company serves pharmaceutical and biotech firms, donor organizations and tissue banks, as well as research and academic organizations around the world. BioStorage Technologies maintains US FDA 21 CFR Part 11 compliant validated technology and tracking systems and adheres to global regulatory agency guidelines and regulations, as well as International Air Transport Association logistics certification and guidelines and US Department of Transportation guidelines.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioProcessing Solutions Alliance Wins Million Veteran Program Genotyping Contract
The U.S. Department of Veterans Affairs awarded a five-year contract for genotyping to the BioProcessing Solutions Alliance.
Friday, November 08, 2013
BioStorage Expands its Service Offering to Include Advanced Bioprocessing Solutions
Company has developed a strategic and innovative alliance with RUCDR Infinite Biologics.
Wednesday, August 22, 2012
Scientific News
Controlling DNA Repair
Scientists discover that DNA repair outcomes following CRISPR-Cas9 cleaving are non-random and can be harnessed to produce desired effects.
Gene Therapy Via Ultrasound
Research into a gene therapy approach called sonoporation could help combat heart disease and cancer.
Stem Cell Therapy Heals Injured Mouse Brain
A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.
Challenging Stem Cell Fate Control
Researchers have found that the fate of stem cells is not only controlled by their local niche, but also by a cell-intrinsic mechanism.
Zika Proteins Responsible for Microcephaly Identified
Researchers have undertaken the first study to examine Zika infection in human neural stem cells from second-trimester fetuses.
Heart Muscle from Stem Cells Aid Cardiovascular Medicine
Researchers discover heart muscle cells from stem cells mirror expression patterns of key genes in donor tissue.
Examining New Hypotheses for Undiagnosed Patients
UnDx Consortium gathers in San Diego to create new paths to identifying currently undiagnosed illnesses.
Novel Therapeutic Approach for Blood Disorders
Gene editing of human blood-forming stem cells mimics a benign genetic condition that helps to overcome sickle cell disease and other blood disorders.
Bone Marrow Transplants Without Using Chemotherapy
Scientists have devised a way to destroy blood stem cells in mice without using chemotherapy or radiotherapy, both of which have toxic side effects.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!